Back to search

Article

Measuring Effectiveness of Treatments in Rare Disorders, Evidence from Clinical Trials in Fragile X Syndrome

2023-10-23

Abstract excerpt

Fragile X Syndrome (FXS) is the leading cause of inherited intellectual disability and autism spectrum disorder (ASD). It results from mutations of the FMR1 gene and the subsequent loss of Fragile X mental disorder 1 protein (FMRP). FXS has been the focus of intense preclinical research leading to several clinical trials. Effect sizes compare the effectiveness of treatments for neurodevelopmental disorders, such a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f2b2cc7a-7d4f-5f92-87a9-5df9536bc448
DOI
10.21203/rs.3.rs-3439158/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Measuring Effectiveness of Treatments in Rare Disorders, Evidence from Clinical Trials in Fragile X SyndromeDOI 10.21203/rs.3.rs-3439158/v1
Select a neighboring publication to make it the new centre.